Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease


Creative Commons License

Diller G., Dimopoulos K., KAYA M. G. , Harries C., Uebing A., Li W., et al.

HEART, cilt.93, ss.974-976, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 93 Konu: 8
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1136/hrt.2006.089185
  • Dergi Adı: HEART
  • Sayfa Sayısı: ss.974-976

Özet

Objective: To examine long-term safety and efficacy of bosentan - an oral dual endothelin receptor antagonist - in patients with pulmonary hypertension associated with congenital heart disease or Eisenmenger's syndrome.